THE CORRESPONDENCE REGISTER
Contact the BPC-157 TB-500 Digest
Correspondence about the Wolverine blend literature — corrections, citations, and questions about the record.
Editorial correspondence only
This is the correspondence register for the BPC-157 TB-500 record. Use the form below for matters about the pages: a correction to a citation, a study worth considering for the record, or a question about how a finding is summarized. Notes about the literature and the regulatory record are read.
What this channel is not: a clinic, a pharmacy, or a prescriber. No medical advice is given, no prescriptions are issued or facilitated, and BPC-157, TB-500, and the Wolverine blend are neither sold nor supplied, nor can anyone be directed to a source. Questions seeking a product, a dose, or a place to obtain either peptide cannot be answered here — those fall outside a reading of the literature, and the Wolverine legal status and 503A compounding page explains why the access question runs only through the lawful prescriber-prescription-compounder pathway [4].
Send a note
Use the fields below. Correspondence about the record is answered as the pages are maintained; requests for medical guidance, dosing, or product sourcing are not. Please keep messages focused on the published literature and the citations on this site.